Optimizing the Patient Experience: A Team Approach.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 2, p. 18
- By:
- Publication type:
- Article
Works matching IS 21644403 AND DT 2025 AND VI 15 AND IP 2
Results: 7
1
2
Monoclonal Antibodies Examined for Use With Multiple Myeloma.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 2, p. 17
- Publication type:
- Article
3
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone Studied for Transplant-Ineligible Multiple Myeloma.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 2, p. 16
- Publication type:
- Article
4
Survey Assesses Nurses Experience With Administering Subcutaneous Delivery of Isatuximab via an On-Body Delivery System.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 2, p. 15
- Publication type:
- Article
5
Results From the GMMG-CONCEPT Trial and the IFM 2020-02 MIDAS Study Highlight Isa-KRd in Newly Diagnosed Multiple Myeloma.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 2, p. 14
- Publication type:
- Article
6
TRACER Initiative Targets Rare Cancers.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 2, p. 10
- By:
- Publication type:
- Article
7
Artificial Intelligence, Algorithms, and Abuse.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 2, p. 6
- By:
- Publication type:
- Article